Handok to introduce transdermal continuous glucose monitoring system
Published: 2009-06-19 06:57:00
Updated: 2009-06-19 06:57:00
Handok Pharm announced on June 15 that it has signed a license agreement with the US based Echo Therapeutics, Inc., under which Echo granted Handok to market, sell and distribute Echo's Symphony™ tCGM (transdermal Continuous Glucose Monitoring) system in Korea.
Echo's Symphony™ tCGM System is ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
